	Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study. Nutr Clin Pract Klassen PN, Kim CA, Kasnik J, Sawyer MB, Ghosh S, Baracos V, Mazurak VC. PMID: 41652656 [PubMed - as supplied by publisher]
	Laparoscopic duodenum-preserving pancreatic head resection in 459 patients for precancerous, cystic neoplasms, and neuroendocrine tumors. Perioperative outcome: systematic review and meta-analysis. Surg Endosc Beger HG, Yinmo Y, Mayer B, Poch B. PMID: 41651957 [PubMed - as supplied by publisher]
	Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized clinical RAMPS trial. BJS Open Holze M, Pianka F, Wittmann M, Photiadis I, Tenckhoff S, Sander A, Balzer A, Klose C, Klotz R, Al-Saeedi M, Loos M, Michalski CW, Hackert T, Heger P, Diener MK, Büchler MW, Hüttner FJ. PMID: 41649934 [PubMed - indexed for MEDLINE]
	Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study. JMIR Form Res Martinez-Gutierrez J, Somasundaram K, Bernardes CM, Rafiq M, Schrader S, Jordan S, Chima S, De Mendonca L, Huckvale K, Hunter B, Manski-Nankervis JA, Lawson J, Anderson K, Milch V, Neale RE, Emery J. PMID: 41649872 [PubMed - indexed for MEDLINE]
	Sarcopenia Affects the Clinical Efficacy of Immune Checkpoint Inhibitors in Gastric Cancer Patients: a Systematic Review and Meta-Analysis. J Gastrointest Cancer Zhang F, Yan Y, Li B, Ge C, Wang Y. PMID: 41649620 [PubMed - in process]
	Pro-inflammatory dietary patterns and their association with cardiovascular disease and pancreatic cancer in a hospital population: a cross-sectional study. Front Nutr Jin Q, Liu Y, Tong Q, Tang B, Liang F, Zeng L. PMID: 41648754 [PubMed]
	17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing? ESMO Gastrointest Oncol William D, Bermúdez M, Kübler A, Kahlert C, Distler M, Weitz J, Uhrig S, Fröhlich M, Hutter B, Aust D, Baretton G, Wimberger P, Kast K, Meisel C, Gieldon L, Porrmann J, Wagner J, Arlt M, Franke M, Fischer J, Hackmann K, Kreutzfeldt S, Mock A, Heilig CE, Lipka DB, Teleanu MV, Schlenk RF, Brors B, Hübschmann D, Paramasivam N, Richter D, Beck K, Pfütze K, Buchhalter I, Weichert W, Herold T, Spiekermann K, Jost PJ, Keilholz U, Klauschen F, Bauer S, Siveke JT, Kindler T, Boerries M, Illert AL, Bitzer M, Schulze-Osthoff K, Schirmacher P, Stenzinger A, Horak P, Heining C, Folprecht G, Fröhling S, Glimm H, Schröck E, Jahn A. PMID: 41647972 [PubMed]
	Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany. ESMO Gastrointest Oncol Lonardi S, Potthoff K, Procaccio L, Yoo C, Macarulla T, Hedouin-Biville F, Prager GW. PMID: 41647964 [PubMed]
	Gastroenteropancreatic neuroendocrine neoplasms in children and adults: a comparative review. Front Endocrinol (Lausanne) Kuhlen M, Claus R, Pavel ME, Kunstreich M, Begum N, Lapa C, Redlich A. PMID: 41647110 [PubMed - indexed for MEDLINE]
	Complete response to BRICS in Locally advanced pancreatic cancer (pMMR, CPS 30): a case report. Front Immunol Yang S, Shao L, Wu Y, Peng Y, Fan W. PMID: 41646856 [PubMed - indexed for MEDLINE]
	Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep Learning. Res Sq Akbar AR, Levya A, Esnakula A, Hasanov E, Noonan A, Manne U, Sahai V, Meng L, Tsai S, Parwani A, Chen W, Manne A, Niazi MKK. PMID: 41646417 [PubMed]
	Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2). ESMO Gastrointest Oncol Shirakawa T, Shimokawa M, Otsuka T, Shinohara Y, Toyodome K, Kusano W, Nakazawa J, Kodama T, Kawahira M, Shimokawa H, Koike T, Koga F, Yunotani S, Nakashita S, Oza N, Noge S, Murayama K, Oda H, Mitsui N, Kawasaki R, Morikita T, Takeshita S, Arima S, Shibata R, Kakihara A, Yoshihiro T, Imajima T, Yamaga S, Arita S, Kawaguchi Y, Nishikawa K, Inagaki T, Otsu S, Taguchi H, Jikuya K, Terada T, Sakai T, Ueda Y, Sakae T, Sawase H, Kawahira M, Nio K, Araki N, Sakai K, Ide Y, Shibuki T, Miwa K, Kubotsu Y, Hosokawa A, Komori A, Honda T, Tsuneyoshi K, Fujita T, Mizuta T, Mitsugi K. PMID: 41646280 [PubMed]
	Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a post hoc analysis of JCOG1213. ESMO Gastrointest Oncol Hirano H, Hirata K, Honma Y, Morizane C, Machida N, Kato K, Okusaka T, Boku N, Sekine S, Hiraoka N, Mizusawa J, Sano Y, Shibuya Y, Takahashi M, Fujimori N, Nomura M, Doki Y, Ueno M, Yoshikawa T, Takeuchi H. PMID: 41646270 [PubMed]
	Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer. Cancer Rep (Hoboken) Wakabayashi A, Tanaka R, Fukumuro Y, Mori K, Sato J, Ishikawa H, Shino M, Kawakami T. PMID: 41645046 [PubMed - indexed for MEDLINE]
	Mitophagy in pancreatic cancer: mechanistic insights and implications for novel therapeutic strategies. Cell Death Discov Wang Z, Lyu Z, Palmen R, Bao Q, Popp F, Dong Q, Bruns CJ, Zhao Y. PMID: 41644524 [PubMed - as supplied by publisher]
	Corrigendum to "Study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay)" [Eur. J. Oncol. Nurs. 76C [2025] 102898]. Eur J Oncol Nurs Rolin L, Hald C, Nielsen D, Theile S, Christiansen AB, Oksen MS, Lundstedt B, Tesfaldet M, Belli SL, Horsted CB, Johansen JS, Chen IM. PMID: 41644314 [PubMed - as supplied by publisher]
	Pancreatic schwannoma: a diagnostic dilemma of pancreatic head tumour. BMJ Case Rep Gupta H, Darshanik DS, Gupta P, Nada R, Rana SS, Gupta R. PMID: 41644196 [PubMed - indexed for MEDLINE]
	Acinar cell plasticity and subtype specification during acinar-to-ductal metaplasia and pancreatic cancer progression. Biochim Biophys Acta Rev Cancer Gautam B, Sharma A, Jatavath M, Pothuraju R, Chaudhary S, Gautam SK, Bhatia R. PMID: 41643947 [PubMed - as supplied by publisher]
	Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy. Technol Cancer Res Treat Zhong D, Liang Y, Su Y, Yang Q, Yan H, Huang X, Shang J. PMID: 41642855 [PubMed - indexed for MEDLINE]
	The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50Â°C in Combination with Chemotherapy in Metastatic Cancer Patients. Cancer Res Commun Brancato L, Gorbaslieva I, Rudenko O, Logghe T, van Zwol E, Boulet G, Van den Bossche L, Van den Bossche J, Peeters M, Chapelle T, Saldien V, Vueghs P, Vandamme T, Dankerlui R, Ysebaert D, Bogers J. PMID: 41642747 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58995

Page 1 of 2950



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy